Current role of surgery in the treatment of neurocysticercosis

PT Hamamoto Filho, LF Norcia, A Fleury, MA Zanini - Pathogens, 2024 - mdpi.com
Neurocysticercosis (NCC) is a common parasitic disease of the central nervous system
(CNS) in low-and middle-income countries. The infection is pleomorphic, caused by the …

Neurocysticercosis: an update on diagnosis, treatment, and prevention

R Pineda-Reyes, AC White Jr - Current opinion in infectious …, 2022 - journals.lww.com
Current Opinion in Infectious Diseases Log in or Register Subscribe to journalSubscribe Get
new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …

[HTML][HTML] Calcified neurocysticercosis: demographic, clinical, and radiological characteristics of a large hospital-based patient cohort

JA Bustos, G Arroyo, OH Del Brutto, I Gonzales… - Pathogens, 2023 - mdpi.com
Neurocysticercosis (NCC), the infection of the central nervous system caused by Taenia
solium larvae (cysticerci), is a major cause of acquired epilepsy worldwide. Calcification in …

Transcriptomic analysis of subarachnoid cysts of Taenia solium reveals mechanisms for uncontrolled proliferation and adaptations to the microenvironment

MA Orrego, MW Szczesniak, CM Vasquez… - Scientific reports, 2024 - nature.com
Subarachnoid neurocysticercosis (SANCC) is caused by an abnormally transformed form of
the metacestode or larval form of the tapeworm Taenia solium. In contrast to vesicular …

A recombinant monoclonal-based Taenia antigen assay that reflects disease activity in extra-parenchymal neurocysticercosis

M Corda, J Sciurba, J Blaha, S Mahanty… - PLoS neglected …, 2022 - journals.plos.org
Background Antigen tests for diagnosis and disease monitoring in some types of
neurocysticercosis (NCC) are useful but access to testing has been limited by availability of …

Low responsiveness of peripheral lymphocytes in extraparenchymal neurocysticercosis

ML Romo, R Osorio, A Toledo… - PLoS Neglected …, 2023 - journals.plos.org
Background The morbidity and mortality of extraparenchymal neurocysticercosis (EP-NC)
remain high and effectiveness of current medical treatment is suboptimal. Various factors …

Older age in subarachnoid neurocysticercosis reflects a long prepatent period

F Nateros, E Saenz, H Saavedra… - … American Journal of …, 2023 - pmc.ncbi.nlm.nih.gov
Patients with subarachnoid neurocysticercosis (NCC) are usually older than those with
parenchymal disease. Whether this difference reflects a prolonged presymptomatic period or …

A rapid point-of-care assay for cysticercosis antigen detection in urine samples

L Toribio, S Handali, Y Marin, E Perez… - … American Journal of …, 2023 - pmc.ncbi.nlm.nih.gov
We report a proof-of-concept study using a dipstick assay to detect Taenia solium antigen in
urine samples of 30 patients with subarachnoid neurocysticercosis and 10 healthy control …

Albendazole–Ivermectin combination decreases inflammation in experimental neurocysticercosis

RC da Silva Santana, TP Prudente… - Experimental …, 2023 - Elsevier
Neurocysticercosis (NCC) is a public health issue in endemic regions and is considered the
main preventable cause of neurologic disease. It is caused by the presence of Taenia …

[HTML][HTML] Oxidative Stress in the Murine Model of Extraparenchymal Neurocysticercosis

D Generoso, TC Martins, CRC Camacho… - Microorganisms, 2024 - mdpi.com
Oxidative stress is associated with several infectious diseases, as well as the severity of
inflammatory reactions. The control of inflammation during parasite destruction is a target of …